Equine Diagnostic Services Market

Equine Diagnostic Services Market Outlook 2025 to 2035

The equine diagnostic services market is USD 689.4 million in 2025, as per Fact. MR's study shows that the industry valuation will advance at a CAGR of 6.3% and reach USD 1,267.1 million by 2035. Its expansion is driven primarily by the increasing prevalence of equine infectious diseases and musculoskeletal disorders, compelling the stakeholders to use more sophisticated and accurate diagnostic equipment and services via veterinary clinics, research centers, and equine hospitals. The sector will eventually move within the next ten years to more automated, technology-based diagnostic platforms than current testing practices.

Real-time PCR, biomarker-based tests, and portable imaging systems are being deployed increasingly as industry standards for quicker turnaround times and better prognosis outcomes. With equine sport and leisure horse ownership on the rise in industrialized economies, there is increasing demand for spending on preventive and diagnostic care.

Parallel to this, emerging economies are experiencing increased organized equine healthcare infrastructure, further cementing growth in the equine diagnostic services market. Diagnostic labs and veterinary clinics are also speeding up alliances with biotechnology firms to develop more targeted assays and imaging devices tailored to equine species. These alliances are also propelling the deployment of tele-veterinary diagnostics, particularly useful in remote or under-served areas.

The expanded surveillance for zoonotic disease has stimulated increased use of diagnostic tests originally designed for human medicine, now applied to equine testing. Industry fragmentation remains a problem, with service models varying by location and facility capability. This is being addressed increasingly through consolidation of diagnostic laboratories and establishment of standard operating procedures. Also, growing concerns about antimicrobial resistance in equine practice are making veterinarians give top priority to diagnostics over treatment, which is positively affecting the rates of service use.

In the long term, the miniaturization of imaging devices and the trend of AI-powered diagnostic analytics will redefine diagnostics for field applications. Investors in genetic profiling technologies, cloud-based data integration, and mobile diagnostic units are going to be among the leaders catering to high performance.

Key Metrics

Fact.MR Survey Results: Industry Dynamics Based on Stakeholder Perspectives

Stakeholder feedback supports accuracy, accessibility, and affordability as the cornerstones characterizing the equine diagnostic services industry. With 82% of interviewees identifying early and accurate diagnosis as mission-critical, especially for performance-driven industries such as racing and dressage, the momentum is building towards advanced imaging, AI-driven evaluations, and real-time biomarker screening.

Concurrently, 75% of websites reported a need for mobile or in-clinic diagnosis to reduce logistic lag and improve treatment responsiveness, an industry-wide push for testing infrastructure decentralization. Across geographies, digitalization and predictive analytics are not only being seen as operational enhancers but also as competitive enablers. Patterns of technology adoption vary, but the trajectory is clear.

North America is leading in AI-aided imaging and gait analysis devices, whereas Europe is concentrating on sustainable, integrated lab environments to go along with veterinary green activities. Asia-Pacific concentrates on price and portability, as nearly two-thirds of the stakeholders listed portable diagnostics and affordable test kits as their priority areas to invest in.

These preferences are directly correlated to regional industrial maturity, horse demographics, and infrastructure limitations and signify divergent investment streams requiring highly localized service models. Supply chain stability and infrastructure constraints were consistently cited as adoption barriers.

From Asian-Pacific power volatility to European import controls and device affordability barriers in North America, the deployment environment for diagnostics is the deciding factor. In the years to come, global stakeholders will make a beeline for AI, wearable monitoring networks, and interoperable platforms-technologies perceived as integral to standardizing diagnostics and preventive large animal health scalability.

Shifts in the Market from 2020 to 2024 and Future Trends 2025 to 2035

Between 2020 and 2024, the equine diagnostic services market grew consistently owing to rising awareness of equine health and diagnostic technology improvements. The increased incidence of equine disease and injury required advanced diagnostic equipment and services. Veterinary clinics and hospitals integrated state-of-the-art imaging modalities such as MRI and CT scans to enhance diagnostic accuracy.

Furthermore, the introduction of mobile diagnostic centers increased access for equine owners living in remote places. However, shortcomings such as the high cost of operation and the need for specialized education for veterinary specialists persist.

Prior to 2025 to 2035, the equine diagnostic services market is expected to continue its growth trend. The growth will be fueled by ongoing innovation in diagnostic technology, increasing investments in equine care, and increasing popularity of horse sports globally.

The Asia-Pacific and Latin America regions will show good growth, driven by growing disposable incomes and equine health consciousness. The integration of artificial intelligence and machine learning in diagnostics will further enhance the accuracy and efficacy of diagnostics.

A Comparative Market Shift Analysis 2020 to 2024 vs. 2025 to 2035

Country-wise Analysis

The USA

The USA equine diagnostic services market will advance at 5.9% CAGR through the course of the study. A strong equine population and good veterinary infrastructure are key drivers of the industry. Higher awareness of early disease diagnosis and preventive healthcare in horses is greatly contributing to demand. The growing interest in equestrian sports and recreational horse riding is further propelling growth in the equine diagnostic services market. Access to sophisticated diagnostic modalities, including molecular diagnostics, imaging technologies, and point-of-care testing, is improving service effectiveness.

UK

The UK equine diagnostic services market will increase at 5.2% CAGR from the study period. A long-established equestrian sector and increasing spending on companion animal health are driving growth. Government and private policies supporting animal well-being and preventive healthcare measures are driving the utilization of diagnostic services. Implementing advanced diagnostic methods, such as PCR testing and digital imaging, is picking up pace in equine veterinary clinics.

Increased incidence of infectious diseases and musculoskeletal conditions in horses is fueling the need for prompt and precise diagnostics. Rising collaborations between veterinary schools and diagnostic service providers are further helping the growth of this industry.

France

France's equine diagnostic services market is likely to grow at 5.0% CAGR over the study period. A strong equine sports culture and growing concerns for equine health management are contributing to its growth. Technological improvement in diagnostic methods and equipment is allowing for quick and precise identification of diseases. Government initiatives favoring animal welfare programs are increasing awareness regarding preventive healthcare among horse owners.

The use of laboratory-based and on-site diagnostic services is growing, fueled by the demand for quick disease management. Advances in imaging and molecular diagnostics are anticipated to expand the industry further.

Germany

The German equine diagnostic services market is expected to grow at 5.3% CAGR over the forecast period. The nation's rich culture in horse riding sports and high registration of horses are having a positive influence on the demand for diagnostic services. Sustained technological developments in equine healthcare, such as the adoption of AI and advanced imaging technology, are driving growth.

Growing focus on early disease diagnosis and thorough health evaluations is encouraging the utilization of diagnostic services. Veterinary clinics and hospitals increasingly implement advanced diagnostic solutions, furthering service capability and operational performance.

Italy

The Italian equine diagnostic services market is anticipated to progress at 4.8% CAGR in the study timeframe. Increased concern for equine health, particularly for sport horses and breeding animals, is enhancing demand for diagnostic services. Marketing campaigns for preventive veterinary care are becoming more powerful, leading to increased use of diagnostic solutions. The use of portable diagnostic machines and point-of-care testing is making disease management efficient and timely.

Growing cases of infectious and metabolic diseases in horses are emphasizing the use of overall diagnostic methods. Improved laboratory facilities and imaging systems are further propelling growth in the equine diagnostic services market.

South Korea

The South Korean equine diagnostic services market is likely to grow at a 5.4% CAGR during the forecast period. Increasing interest in equine sports and keeping horses as pets is driving robust demand for diagnostic services. Substantial investments in veterinary healthcare infrastructure and technological advancements are increasing access to sophisticated diagnostic facilities. Initiatives by the government aimed at animal health and welfare are having a positive impact on dynamics.

Growing numbers of specialized veterinary clinics providing equine care are generating new growth opportunities. Embracing innovative diagnostic platforms and integrating digital technologies will be crucial for growth.

Japan

Japan's equine diagnostic services market will grow at a 5.1% CAGR throughout the study period. A consistent increase in horse racing events and equestrian activities is driving demand for equine diagnostic services. Advanced veterinary technology, complemented by a high regard for animal welfare, is enabling early disease detection and control. Increased incidence of age-related disorders among horses is calling for more extensive diagnostic interventions.

Spending on veterinary research and development also enhances service capabilities. Increased use of telemedicine and remote diagnostics is improving access and convenience for horse owners as well as veterinary practitioners.

China

The Chinese equine diagnostic services market will be growing at a rate of 6.4% CAGR over the forecast period. Exponential growth in the horse industry and investment in veterinary healthcare facilities are significant growth drivers. Improving disposable income and a shift in consumer attitude toward animal health are fueling enhanced demand for diagnostics. Embracing high-tech diagnostic equipment, including molecular testing and imaging, is gaining popularity in veterinary clinics and hospitals.

Government policies implemented to improve animal health levels are promoting preventive diagnostics usage. Domestic and foreign service providers' solid presence is also boosting competitiveness.

Australia-New Zealand

The Australia-New Zealand equine diagnostic services market will rise at 5.5% CAGR throughout the study. The high equine population and high cultural inclination toward horse sports are key drivers of growth. Government and private initiatives of animal health and welfare are providing positive conditions. The growing adoption of digital diagnostics and handheld testing kits is improving efficiency and accuracy in managing diseases.

Growth in equine veterinary services and increased emphasis on preventive healthcare are driving the use of diagnostic services. Joint efforts of veterinary institutes and technology developers will shape future developments.

Segment-wise Analysis

By Service Type

The Infectious Disease Testing segment will lead the Diagnostic Services Market in 2025, commanding about 40.3% of the total share, while Genetic Testing will have an estimated share of about 30.1%.

Infectious Disease Testing is mainly driven by increasing incidences of infectious disease and the consequences of worries that emerge around global threats to health, including emerging infectious diseases and pandemics. Increased travel, migration, and trade around the globe heighten the risk of cross-border transmission, making routine testing for rapid infectious disease diagnosis and prompt treatment essential.

Hospitals, clinics, and health departments are focusing on the implementation and expansion of contagious disease screening programs for common tests such as influenza, tuberculosis, and HIV and other specialized tests for malaria, dengue fever, and COVID-19.

Major diagnostic companies such as Roche, Abbott, and Siemens Healthineers are continuously innovating toward faster, more accurate, and cost-effective diagnostic solutions, including multiplex assays that can detect various pathogens at once. Therefore, improved access and affordability in infectious disease testing have also favored the growth of the industry.

The demand for genetic testing services has gained momentum with increasing interest in personalized medicine, precision diagnostics, and preventive health care. Genetic tests identify individuals at risk for some hereditary conditions, evaluate their genetic predisposition to diseases, and tailor relevant treatment plans based on these.

With decreasing costs of genomic sequencing, genetic tests have become increasingly available for consumers and healthcare providers. Genetic testing, hereditary disease screening, pharmacogenomics (assessment of the influence of genes on drug response), and cancer genomics-where tests identify the genetic mutations associated with types of cancer-have attracted much attention.

Key players in the genetic testing industry, including Illumina, Thermo Fisher Scientific, and 23andMe, are pushing the advancement of next-generation sequencing (NGS) technology to enable comprehensive and accurate genetic testing in clinical and consumer markets.

By Service Setting

It is expected that in 2025, Hospitals & Clinics will lead the Diagnostic Services Market by a whopping 58.5% share of the entire industry as compared with Lab Testing & Mobile Settings, contributing to only a mere 41.5%.

Hospitals & Clinics will continue to capture a larger share of the industry due to their unique role in comprehensive medical care. It is through these institutions that advanced diagnostic facilities will provide various services such as imaging tests, blood tests, and specialized screening for a variety of medical conditions.

They are particularly useful for people who require complex diagnostic procedures such as surgeries, specialized tests, and acute care diagnostics. The high inpatient and outpatient needs of hospitals and clinics for sophisticated diagnostic equipment are bringing about diagnostic services activities. The creation of healthcare infrastructure, especially in developing regions, will only add to this increasing demand for centralized diagnostic services in hospitals and clinics.

Lab Testing & Mobile Settings are expected to enjoy a good share of the annual growth in revenue size, ending 2025 at 41.5%. The advent of laboratory-testing services, notably point-of-care testing and home diagnostics, rapidly changed the methods and places in which patients access diagnostic services. Home testing kits are those that grant freedom to perform tests in their homes.

At the same time, mobile health services include mobile blood collection units and diagnostic vans, the latter being highly popular for their convenience and access to the masses. These settings serve populations with little or no access to traditional healthcare facilities, such as those in rural areas and underserved regions.

Furthermore, telemedicine and mobile diagnostics account for quicker turnaround times, shorter waiting periods, and less money spent by patients. Everly well and LabCorp are examples of companies offering services that drive this transformation and make lab testing more accessible outside the walls of conventional healthcare.

Competitive Outlook

The equine diagnostic services market is rapidly developing because of advancements such as genetic testing, diagnostics for infectious diseases and veterinary imaging in the equine field. IDEXX Laboratories Inc., with its comprehensive diagnostic portfolio, emerges as one of the leaders, having a wide variety of equine-specific laboratory tests, including infectious disease panels and health screenings. Neogen Corporation further entrenches its position with specific equine DNA testing, particularly with regard to breed verification, disease susceptibility, and performance traits.

The Veterinary Genetics Laboratory (VGL) at UC Davis is still on top of research-oriented diagnostics, offering trusted genetic tests influencing breeding, performance evaluation and disease management. Animal Genetics Inc. and VetGen have equally been able to secure quite a strong foundation through a highly specialized focus on hereditary diseases and color genetics, reaching breeders and veterinary practitioners across North America and Europe.

On the other end of the continuum, new blood such as Etalon Inc., Equiseq Inc., and Equine Diagnostic Solution Inc. are coming up with next-generation sequencing (NGS)-based panels, predictive analytics for performance, and personalized equine health care. In addition, regional veterinary centers such as B&W Equine Vets are now integrating diagnostics into their clinical services, where they will provide end-to-end health management solutions. Speed of testing, breadth of diagnostic panels, and integration of genetic evidence in preventive equine care become the differentiators in competition.

Market Share Analysis by Company

Key Company Insights

IDEXX Laboratories Inc. leads the equine diagnostic services market and accounts for about 20-24% of the share using a complete portfolio of equine infectious disease diagnostics, wellness panels, and laboratory services. Its already-established global network of veterinary laboratories, investments in point-of-care testing, and rapid service delivery ensure robust client relationships.

Also, Neogen Corporation prices about 16-20% of the industry, focusing on genetic testing and health screening for horses. Solutions are targeted at breed registries, veterinary clinics, and individual horse owners with panels that address hereditary conditions, coat color genetics, and performance traits. Nonstop expansion of predictive and preventive diagnostic capabilities continues in Neogen's innovation pipeline.

Veterinary Genetics Laboratory (VGL) holds a share of about 12-15% and is recognized internationally for its research-based genetic tests. Affiliated with the University of California, Davis, VGL provides one of the most established repositories for equine DNA diagnostics, serving breeders, veterinarians, and researchers alike. Animal Genetics Inc. holds around 10-13% of the share and offers a comprehensive suite of DNA tests, from parentage verification all the way through disease diagnosis.

International presence and low-cost strategies make it a top choice for breeders and veterinarians looking to have reliable genetic insights. VetGen apparently accounted for 8-10%, focusing primarily on inherited disease testing and genetic counseling concerned with equine health management. Its differentiated breed-specific and condition-specific panels further boost the interest among specialist veterinarians and breed associations in VetGen.

Key Players

• Generatio GmbH
• Equiseq Inc.
• VetGen
• Animal Genetics Inc.
• Veterinary Genetics Laboratory
• Etalon Inc.
• Equine Diagnostic Solution Inc.
• IDEXX Laboratories Inc.
• B&W Equine Vets
• Neogen Corporation